Filing summary
Entity and period: The supplied filing is Virtual Crypto Technologies, Inc.’s Form 10-K for the fiscal year ended December 31, 2018, filed March 29, 2019. This does not match the request metadata naming QUANTUM X LABS INC.; the filing itself does not identify that company. Although the metadata says “2018 Q4,” this is an annual report.
Business context
In 2018, the company shifted from its former DermaCompare digital-health business, which it ceased and placed into liquidation, to developing cryptocurrency transaction software and hardware for ATMs and other devices through its Israeli subsidiary. The new business was at an early stage and had no established recurring revenue. Its sole reported customer, Chiron, paid $100,000 under a distribution term sheet; after Chiron encountered financial difficulties, the company said it would no longer pursue that arrangement.
Financial performance and liquidity
| Metric | FY 2018 | FY 2017 |
|---|---|---|
| Revenue | $100,000 | $0 |
| Research and development expense | $790,413 | Not separately reported |
| General and administrative expense | $1,773,839 | $557,300 |
| Operating loss | $2,464,252 | $557,300 |
| Net loss | $25,006,486 | $1,573,906 |
| Net cash used in operating activities | $1,544,053 | $630,015 |
| Cash and cash equivalents at year-end | $499,919 | $2,959 |
| Current assets | $558,677 | $15,181 |
| Current liabilities | $975,153 | $1,011,941 |
| Working capital | Deficit of $416,476 | Deficit of $996,760 |
The 2018 net loss included $22,542,234 of net financing expense, principally a reported $21,622,897 loss associated with changes to convertible-note terms. The filing reports no gross margin. Financing cash flow was $2,041,013, including approximately $1.94 million from stock and warrant issuance and $100,000 from convertible notes. Total liabilities were $975,153, including $485,449 of short-term convertible notes and $469,525 of liabilities held for sale related to the former subsidiary.
Common shares outstanding were 110,748,391 at December 31, 2018 and 110,749,643 at March 28, 2019. The company issued substantial equity and warrants, and reported shares and warrants issued for services as a significant noncash expense.
Changes, outlook and risks
- Revenue rose from zero, but came entirely from one customer relationship that ended; the filing reports no recurring revenue.
- The company spent $790,413 on research and development and said cryptocurrency-market weakness and regulatory uncertainty reduced anticipated demand. It had no firm manufacturing arrangements and identified product development, market acceptance, regulation, technology, cybersecurity and access to financing as material risks.
- Management said available funds were expected to support its business plan through December 2019, while also stating that additional financing was necessary. The auditor’s report raised substantial doubt about the company’s ability to continue as a going concern. The financial statements include no adjustments for the outcome of that uncertainty.
- After year-end, the company agreed to exchange shares for Algomizer Ltd.’s 99.83% interest in Viewbix Ltd. The proposed transaction would give Algomizer 65% of the company on a fully diluted basis at closing, with potential additional shares and warrants. Closing was conditional and not assured.
- Stockholders approved a proposed 1-for-15 reverse split in February 2019, but the filing says it would take effect only after required approvals. Convertible notes were extended in January 2019 through January 2020.
- Material contingencies include the former subsidiary’s liquidation and employee claims (less than $96,000, included in liabilities) and a former executive’s $100,000 wrongful-dismissal claim, for which no provision was recorded. The company said it believed the latter claim was unlikely to succeed.
Most important facts to verify
- Confirm the issuer identity: the source is a Virtual Crypto Technologies, Inc. 10-K, not a filing identifying QUANTUM X LABS INC.
- Reconcile convertible-note conversion disclosures: the filing contains inconsistent share-conversion figures, including a stated 465,172,000-share conversion at $0.01 that does not reconcile with the financial statements’ reported share totals.
- Check warrant terms: the filing gives conflicting Class F and Class G exercise prices in different sections.
- Verify the company’s post-year-end liquidity, financing obtained, note repayment or conversion status, and whether it remained able to continue as a going concern.
- Confirm whether the Viewbix transaction and reverse split closed, and assess the resulting ownership, dilution and capital structure.
- Review the status and resolution of the former subsidiary’s liquidation, employee liabilities and litigation claims.